Similarly, in nodules with Bethesda III cytology, the BCR was higher for ATA non-high-risk US nodules compared to the ATA high-risk nodules (89% vs 74%, P = .086), though this difference did not reach statistical significance.
← all excerpts
Ultrasound Features and Performance of Afirma Gene Sequencing Classifier in Cytologically Indeterminate Thyroid Nodules.
1
—
—